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Ripudaman K Bains is the editor of the Genome
Biology special issue content on the ‘genomics of
infectious diseases’, and introduces the collection in
this editorial.cine distribution strategies or environmental approaches.Editorial
Over the past few years there has been what can only be
described as an explosion in the field of pathogen gen-
omics. This has been predominantly facilitated by the
availability of quicker and cheaper sequencing technolo-
gies, but also, and not insignificantly, by substantial pol-
itical pressure and increased funding from numerous
governmental and philanthropic organisations. Despite
this, the devastating global burden of infectious diseases
is far from being alleviated; the recent outbreak of Ebola
virus serves as a reminder of how infectious diseases
continue to disproportionately affect the truly destitute
in economically developing regions. However, the land-
scape of infectious diseases is changing, as demonstrated
by the recent re-emergence of Dengue fever in Japan, for
the first time in 70 years [1]. This has reignited concerns
about shifting transmission dynamics of communicable
diseases, including how climate change is likely to affect
their global spread, and it has reiterated the need for
political action to meet challenges in the near future.
It is against this backdrop that Genome Biology and
Genome Medicine publish this collaborative and particu-
larly timely issue on the ‘genomics of infectious diseases’.
In this endeavour, we are indebted to our Guest Editors,
Professor George Weinstock and Professor Sharon Pea-
cock, for their invaluable advice and guidance. We are
also extremely grateful to all authors who submitted
manuscripts, and to the many reviewers who provided
feedback and advice.Correspondence: Ripudaman.Bains@genomebiology.com
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Genomic approaches have not always been available for
infectious disease research, or for guiding prevention
programmes. Some of the most ambitious and successful
eradication programmes of the 20th century utilised vac-
These included the Global Polio Eradication Initiative,
which began in the 1950s and involved a global immun-
isation programme, and the Guinea Worm Eradication
Program, which focused on improving sanitation and ac-
cess to clean and safe water supplies.
The potential for genomic studies to transform our
understanding of pathogens was initially realised with
the completion of the first pathogen sequencing project:
that of Haemophilus influenzae in 1995, after decades of
work [2]. Encephalitozoon cuniculi was the next patho-
gen to have its genome completely sequenced in 2001
[3], followed by Plasmodium falciparum in 2002 [4].
The significance of these pioneering genomic studies
should not be underestimated; since their completion,
genome approaches have revolutionised the study of
pathogens. For example, for some infectious diseases,
genomics-based studies have elucidated how and why
drug resistance emerges by identifying genomic signa-
tures. They have also enabled researchers to retrospect-
ively analyse where and why the outbreak of a particular
disease occurred; examples of such an approach include
studies of Legionnaires’ disease [5], severe acute respira-
tory syndrome [6], bird influenza [7], and global epi-
demics - including the current Ebola outbreak that is
ravaging West Africa [8]. Sequencing technologies them-
selves also have incredible potential for diagnosing previ-
ously uncharacterised pathogens, as shown in the Genome
Biology article on a rare brain tapeworm [9]. Genomics
therefore has an important and multifaceted role in the fu-
ture control of infectious diseases.
The increased number of genomic studies of infectious
diseases has not been without controversy. One of the
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viruses could acquire mutations and become pathogenic,
a feat for which he was named one of Time magazine’s
100 most influential people of 2012 [10]. After a lengthy
court battle, a Dutch district court in Haarlem ruled that
Fouchier had not followed European Union restrictions
on preventing the proliferation of weapons of mass de-
struction and so-called dual-use technology that could
be used for good or evil [11]. The court’s decision led to
heated debates about the importance of academic free-
dom, and concerns about the future of infectious disease
genomics research.Where do we go from here?
Despite the potential setback of the Fouchier ruling, gen-
omic approaches continue to be utilised to address a
wide range of questions in pathogen research, which is
evidenced by topics presented in this special issue. The
use of chemotherapy has been a mainstay of disease
control programmes since the 1950s, and the emergence
of drug resistance remains a global health concern. In
one of our featured reviews, Elizabeth Winzeler and Micah
Manary discuss the growing problem of artemisinin resist-
ance in malaria-endemic regions [12], and how genomic
studies have identified the signatures of resistance.
In another review [13], Flaminia Catteruccia and col-
leagues discuss different approaches for engineering mos-
quito populations. This review is particularly timely given
the 2012 ruling by the Brazilian government to allow a
longitudinal field trial of genetically modified mosquitoes
for the control of Dengue fever [14]. This decision was
not without opposition, perhaps most notably from envir-
onmental groups. In light of the recent re-emergence of
infectious diseases in many areas of the world, this contro-
versial method of vector control is likely to become more
commonplace.
In the midst of the excitement about high-throughput
approaches, it is important to remember that such methods
are not always affordable or practical in endemic regions.
As shown in the Genome Biology paper by Pardis Sabeti
and colleagues [15], the optimisation of existing, accurate
and cheap technologies is a suitable option for the rapid
diagnosis of Ebola and Lassa viruses. In the drive towards
ever more sophisticated technologies, this work is a hum-
bling reminder that they are not always an option in re-
gions in which the problems are most pressing.Empowering genomics research at regional and
international levels
The ongoing Ebola crisis has highlighted the need for
co-ordinated international responses to tackle disease
outbreaks. This is only possible through collaborative re-
search, and in recent months a number of institutionshave been established to address this need at both re-
gional and international levels.
In a Comment article from Christian Happi and col-
leagues [16], the authors address the imbalance between
genomics research capabilities within and outside Africa,
a continent with a significant proportion of the global
burden of infectious diseases. The establishment of the
African Center of Excellence for Genomics of Infectious
Diseases empowers African genomicists to take the lead
in developing solutions for their control. This institute is
an indication of how economically developing regions
are likely to increasingly take the lead in collaborative
research projects to help address both regional and glo-
bal problems.
Genome Biology and infectious disease genomics
Genome Biology received over 100 manuscripts for con-
sideration in this special issue. The wealth of topics cov-
ered in the submissions demonstrates not only how far
the field has come but also how exciting and broad the
research continues to be. It is clear that genomics has a
vital role in research into the biology of infectious dis-
eases, as well as in finding innovative solutions to their
control. The journal will continue to publish novel and
important research within this area following this special
issue.
Concluding remarks
We hope that you find this collection of articles interest-
ing, informative and useful. However, it is with regret
that we must also mention that an author of one of the
published manuscripts sadly passed away in Sierra Leone
after losing his fight against Ebola, after working to col-
lect strains of the virus. We hope that in addition to
showcasing cutting-edge research into human pathogen
genomics, this special issue also reminds our readers of
the devastation that these diseases continue to cause,
and the risks to those who work on the frontline to de-
feat them.
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